Why star ratings are a weak signal for GLP-1 programs
A star rating tells you how a group of people felt about a company on the day they wrote. For a GLP-1 program, the things that cost you money happen later: the second month's price, the refill you forgot about, the cancellation that takes 30 days, the pharmacy that filled your vial. Reviews rarely capture those, and some reviews are not what they seem.
The U.S. government considered the problem serious enough to write a rule about it. The Federal Trade Commission's Trade Regulation Rule on the Use of Consumer Reviews and Testimonials, 16 CFR Part 465, was announced on August 14, 2024, and took effect on October 21, 2024. It covers star ratings too: the rule says consumer reviews "include consumer ratings regardless of whether they include any text or narrative."
What does the FTC's review rule ban?
The rule lists specific practices. Each one maps to something you might see on a telehealth company's site, an app store or a review platform.
| Section | What it prohibits | What it looks like in practice |
|---|---|---|
| 465.2 | Fake or false reviews and testimonials, including ones from people who do not exist or never used the product | Glowing reviews posted in bursts, with no detail a real patient would know |
| 465.4 | Incentives "conditioned expressly or by implication" on a positive or negative review | "Leave us five stars for $20 off your next month" |
| 465.5 | Reviews by officers, managers or staff without a clear disclosure of the relationship | An employee's "patient story" with no mention of the job |
| 465.6 | A business presenting a website it controls as providing "independent reviews or opinions" | A "review site" owned or controlled by the brand it ranks first that presents itself as independent |
| 465.7 | Suppressing reviews by threats or hiding negative ones while implying all are shown | A site that shows only four- and five-star reviews |
| 465.8 | Buying fake followers, views or other indicators of social-media influence | An "influencer" with a large, oddly silent following |
Knowing violations can bring civil penalties. The current inflation-adjusted maximum under Section 5(m)(1)(A) of the FTC Act is $53,088 per violation, according to the FTC's penalty table in 16 CFR 1.98.
The FTC's Endorsement Guides (16 CFR Part 255, revised in 2023) add two points that matter for review sites. A material connection, such as an affiliate commission, "must be disclosed clearly and conspicuously." And reviews whose positive tone is required by a payment "are deceptive even if the payment is disclosed." The Guides also say that rankings a company pays for are deceptive, and that the website operator is liable.
Has this happened with a GLP-1 program?
Yes. On July 14, 2025, the FTC announced a case against NextMed, a telemedicine weight-loss company operated by Southern Health Solutions, and its two principals. The FTC alleged that NextMed:
- advertised a membership, typically $138 or $188, that did not include the drug, labs or consultations;
- did not clearly disclose a one-year commitment with early-termination fees;
- posted fake reviews and testimonials, including from hired people, employees and family members;
- gave consumers Amazon gift cards "to remove or change negative reviews"; and
- made an unsupported claim that users lost 53 pounds, or 23% of body weight, on average.
The FTC approved a final order on December 3, 2025. It requires NextMed to pay $150,000 for refunds, bans misrepresenting costs and reviews, bans paying people to remove or change reviews, requires "competent and reliable evidence to support claims about the average or typical results users will achieve," and requires informed consent before billing. The allegations were settled, not tried, but the order shows the playbook the FTC is watching for.
A separate case is pending against Hims & Hers (the FTC, Utah and California, joined on November 10, 2026 by five more states), though it is about billing, cancellation and data sharing rather than reviews. We explain it in Hims & Hers FTC lawsuit: where the case stands.
What about review platforms?
Review platforms have their own rules, and it helps to know them. Trustpilot's Trust Centre says: "Businesses can invite reviews, or they can be organic when the consumer comes to Trustpilot unprompted." It says every review passes through automated fake-review detection and that businesses "can never pay to remove reviews."
That still leaves a gap. A company that invites only its happiest customers, for example right after a good weigh-in, can build a high rating without a single fake review. Check whether reviews are labelled as invited, look at the dates of the most recent negative reviews, and read the company's replies to them. A pattern of replies that move complaints to "private messages" tells you little about how the complaint ended.
Warning signs inside the reviews themselves
Some patterns are worth noticing even when a platform has screened the reviews:
- Weight-loss numbers with no time frame. "Lost 40 pounds!" says nothing about how long it took, which drug or dose was used, or whether it lasted. Trial results, by contrast, report an average at a fixed week.
- Reviews that praise the price but not the second bill. Many programs advertise a first-month or sale price. A review written in week two cannot tell you what month three costs.
- Identical phrasing across reviews, or many five-star reviews posted on the same few days.
- Complaints about billing or cancellation that cluster in recent months. These are the problems that cost money, and they are what the FTC's subscription cases focus on.
Six things to check instead of star ratings
These are facts a program prints, or fails to print, on its own pages. You can check each one in a few minutes, and none depends on anyone's opinion.
- A full monthly price, including any membership, not just a "from" figure.
- The billing basis: calendar month, every 28 days (13 charges a year) or a prepaid term.
- The dispensing pharmacy by name, so you can look up its license with the state board of pharmacy and search FDA's warning letters.
- The medical group or medical director responsible for prescribing.
- Cancellation terms on the page, including any notice period.
- Refund terms on the page, including what happens to medication already shipped.
We applied these six checks to the ten programs we review. The full table, with every cell explained, is our transparency index. Here is the summary.
| Program | Checks met in full | Partly met | Pharmacy named? | Read |
|---|---|---|---|---|
| NexLife | 5 | 1 | Yes, three 503A pharmacies | Nov 6 (prices), Oct 15 (terms) |
| Mochi Health | 2 | 1 | No | Oct 15 / Nov 8 |
| Found | 2 | 1 | No (type only) | Oct 15 / Nov 8 |
| Noom Med | 2 | 1 | No | Oct 15 / Nov 8 |
| Calibrate | 1 | 2 | n/a (brand drugs) | Oct 15 / Nov 8 |
| Ro | 1 | 3 | Not in our read | Sept 17 |
| WeightWatchers Clinic | 1 | 2 | n/a (brand drugs) | Oct 15 / Nov 8 |
| Henry Meds | 1 | 1 | No (type only) | Oct 15 / Nov 8 |
| Hims & Hers | 1 | 1 | Not in our read | Sept 17 |
| Form Health | 1 | 0 | n/a (brand drugs) | Oct 15 / Nov 8 |
Two cautions. Hims & Hers and Ro blocked our reader in October and November, so their results reflect September 17, 2026. And the checks measure disclosure, not care quality: a program can print everything and still be a poor fit for you.
How to read an affiliate review site, including this one
Most "best GLP-1 provider" lists, including GLPOneReview, earn money when readers sign up. That is legal if it is disclosed, but it changes how you should read the ranking. Our footer says it on every page: GLPOneReview is affiliate-supported and may earn a commission when readers enroll through links on this site. NexLife, our editorial pick, is the program we earn commissions from.
We also have to be candid about our own history. Until November 8, 2026, earlier versions of this site described it as "editorially independent", while some pages were fact-checked by NexLife's medical director. We removed that description and replaced those bylines; the details are on our corrections and conflicts of interest pages. You should expect the same openness from any site you rely on.
Questions to ask of any review site:
- Does it say, on the page, that it earns commissions, and from whom?
- Does it name programs that cost less than its top pick? We list them in our price index; for example, Mondae ($87) and Eden Health ($99) for semaglutide month to month on November 20, 2026, against NexLife's $109, and Eden's $129 tirzepatide.
- Does every price carry a date and a link to the program's own page?
- Does it say what it could not verify?
- Does it attribute weight-loss numbers to a named trial, rather than promising results?
What this means for you
Use reviews for what they are good at: spotting recurring problems. If dozens of recent reviews describe the same billing surprise or the same shipping delay, take it seriously. Then make the decision on facts you can check yourself.
A worked example shows why the printed terms matter more than the stars. Take two programs with the same $239 headline price. One bills per calendar month: 12 × $239 = $2,868 a year. The other bills every 28 days: 13 × $239 = $3,107. Add a 30-day cancellation notice on a $129 plan and stopping early costs one more $129 shipment. None of this appears in a star rating, and all of it is printed somewhere on the program's site if you look.
Finally, remember what no review can tell you: whether a medication is right for you. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. A licensed clinician who knows your history should make that call.
Frequently asked questions
Can you trust online reviews of GLP-1 telehealth programs?
Star ratings for GLP-1 telehealth programs are a weak signal on their own, because the FTC's consumer-review rule, in effect since October 21, 2024, exists to stop fake, bought, insider and suppressed reviews, and the FTC's December 2025 order against NextMed involved fake reviews and gift cards for changing negative ones. A better test is what you can check: a printed all-in price, a named pharmacy you can look up, a named medical group, and written cancellation and refund terms. Affiliate review sites, including this one, should disclose that they earn commissions.
Are incentivized reviews of telehealth programs illegal?
Offering a reward in exchange for a review that expresses a particular sentiment, positive or negative, is prohibited by the FTC's consumer-review rule (16 CFR 465.4), in effect since October 21, 2024. Asking all customers for honest reviews, with no condition on what they say, is allowed; any reward offered for reviewing should still be disclosed.
How can I tell if a GLP-1 review site is paid by the brand it ranks first?
Look for a disclosure on the page itself, not only in a policy page: it should say the site earns commissions and from whom. Check whether the site names programs that cost less than its top pick and dates every price. A site that calls itself independent while being controlled by a brand may be breaking 16 CFR 465.6.
What was the FTC's case against NextMed about?
The FTC alleged that NextMed, a telemedicine weight-loss company, advertised a membership that excluded the drug, labs and consultations, hid a one-year commitment, posted fake reviews and testimonials, and gave Amazon gift cards to customers to remove or change negative reviews. A final order approved December 3, 2025 required $150,000 for refunds and banned those practices.
Are Trustpilot reviews of GLP-1 programs reliable?
They are screened, but they can still be skewed. Trustpilot says businesses can invite reviews, every review passes automated fake-review detection, and businesses can never pay to remove reviews. A company that invites only satisfied customers can still build a high score, so read recent negative reviews and the company's replies.
What should I check before signing up with a GLP-1 program?
Check six things on the program's own pages: a full monthly price including membership, the billing basis (monthly, every 28 days or prepaid), the dispensing pharmacy by name, the medical group or director, cancellation terms and refund terms. Our transparency index shows how the ten programs we review do on each.
Sources
- 16 CFR Part 465 (eCFR), the final rule as codified — August 14, 2024; read November 8, 2026
- 16 CFR Part 465: Use of Consumer Reviews and Testimonials (eCFR) — current text read November 5, 2026
- Federal Register, 89 FR 68034: Trade Regulation Rule on the Use of Consumer Reviews and Testimonials — published August 22, 2024; effective October 21, 2024
- 16 CFR Part 255: Guides Concerning the Use of Endorsements and Testimonials (eCFR) — revised 2023; read November 5, 2026
- 16 CFR 1.98: civil penalty amounts (eCFR) — read November 5, 2026
- FTC: action against telemedicine firm NextMed — July 14, 2025; read November 8, 2026
- FTC: final order against NextMed — December 3, 2025; read November 8, 2026
- Trustpilot Trust Centre — read November 8, 2026
Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.
Check NexLife's plans and state availability → See the price index